- Global Pharma News & Resources

Eight AstraZeneca UK employees recognised in The Queen’s Birthday Honours for their outstanding achievements in life sciences during the pandemic

Eight AstraZeneca employees have been included in The Queen’s Birthday Honours List 2021, recognised for their outstanding achievements in UK life sciences, manufacturing and supporting the UK and Global response to the current pandemic.


Since early 2020 when the true scale of the pandemic became clear, AstraZeneca has committed to harnessing and sharing our scientific knowledge and expertise in the development of diagnostics and medicines. During the pandemic, equal importance has been placed on ensuring patients in the UK and across the world continue to access other critical AstraZeneca treatments including those for cancer, respiratory and cardiovascular disease.


AstraZeneca Executive Vice-President, BioPharmaceuticals R&D, Sir Mene Pangalos, said “I’m delighted that eight of my colleagues have been awarded these special honours by Her Majesty. Equally, I’m incredibly proud of all 81,000+ AstraZeneca employees globally for the role they have played in responding to this pandemic. Many have worked around the clock in the past 12 months and have put their lives on hold to commit to a bigger humanitarian cause, positively impacting the lives of hundreds of millions of people across the globe.”


AstraZeneca is proud to celebrate with its employees who have received honours in this year’s Queen’s Birthday List:

  • Made CBE, Richard Marshall, Senior Vice President and Global Head of Late Respiratory & Immunology
  • Made CBE, Juliette White, Vice President, Global Sustainability
  • Made CBE, David Hunt, Head of Vaccine Operations
  • Made CBE, Mark Proctor, Senior Director, Global Supply Chain
  • Made OBE, Steve Rees, Vice President, Discovery Biology
  • Made OBE, Amanda Leach, Global Clinical Head, Medicines Discovery
  • Made OBE, Richard Turner, Senior Director, Biopharmaceutical Development
  • Made MBE, Jon Elliott, Director, Government Affairs and Policy



These honours recognise individual achievements and symbolise the endeavours of AstraZeneca, in collaboration with the UK life sciences community and Government to turn the tide on the pandemic. The honours awarded to UK citizens at AstraZeneca represent achievements in:

  • Early pandemic response to support AstraZeneca’s 8,300+ employees in the UK to ensure business continuity and uninterrupted supply of medicines to patients across the world
  • Research, development and regulatory preparedness to ensure continued access and supply of AstraZeneca medicines throughout the pandemic and after the UK left the EU
  • Working with partners to develop and build the National test centre in Cambridge to analyse over 100,000 samples each week for the national testing programme




Notes to Editors



AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit and follow the Company on Twitter @AstraZenecaUK.


With its global headquarters in Cambridge, AstraZeneca operates in five different locations in the UK, where around 8,300 employees work in research and development, manufacturing, supply, sales and marketing. We supply 40 different medicines to the NHS. The UK is also an important location for AstraZeneca’s clinical trials; in 2018, we undertook 201 trials in the UK, involving 376 centres and over 7,000 patients.





UK media enquiries


Christian Petrovic, UK Communications Manager – 07385 086354


Katy McMillan, UK Communications Director – 07392 103290

Editor Details

Last Updated: 15-Jun-2021